Consensus report of the Fifth International Forum for Liver MRI

AJR Am J Roentgenol. 2013 Jul;201(1):97-107. doi: 10.2214/AJR.12.9491.


Objective: This article reviews topics discussed during the Fifth International Forum for Liver MRI (with a focus on gadoxetic acid-enhanced MRI), which was held in Munich, Germany, in September 2011.

Conclusion: Growing evidence shows that gadoxetic acid-enhanced MRI has high sensitivity and specificity for diagnosing liver tumors. Hepatobiliary phase imaging adds new information for the characterization of borderline lesions. However, there is a need to develop standardized criteria for interpretation of gadoxetic acid-enhanced MRI in patients with cirrhosis or other risk factors for hepatocellular carcinoma.

Publication types

  • Consensus Development Conference
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Carcinoma, Hepatocellular / diagnosis*
  • Carcinoma, Hepatocellular / pathology
  • Contrast Media*
  • Early Detection of Cancer
  • Gadolinium DTPA*
  • Germany
  • Humans
  • Liver Neoplasms / diagnosis*
  • Liver Neoplasms / pathology
  • Magnetic Resonance Imaging*
  • Practice Guidelines as Topic


  • Contrast Media
  • gadolinium ethoxybenzyl DTPA
  • Gadolinium DTPA